Precision radiation aims to protect brain function while fighting cancer spread
NCT ID NCT05013892
Summary
This study is testing a more precise form of whole-brain radiation therapy designed to protect healthy brain tissue while treating cancer that has spread to the brain. Researchers want to see if this approach helps maintain patients' quality of life and reduces symptoms better than standard treatment. About 41 adults with brain metastases from solid tumors will receive the targeted radiation along with a standard medication called memantine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital Cancer Center
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.